Provides therapies for micro-orphan applications.

Advent Therapeutics was formed by senior industry executives with extensive expertise and proven track records in Neonatal / Pediatric and similar Orphan Drug “niche” markets to address serious unmet medical needs facing underserved patient populations by taking novel advantage of targeted already commercially-available or late-stage therapeutic opportunities – A Platform Approach to serving the most fragile patients.

Industry: Health
Status: Active

Contact Information

david.lopez@advent-therapeutics.com

David Lopez

Founder & CBO

Esq.

CPA